RJA
HQY icon

Raymond James & Associates’s HealthEquity HQY Stock Holding History

Raymond James & Associates’s Portfolio HQY Stock Details HQY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$12.4M Buy
151,318
+1,911
+1% +$147K 0.01% 1096
2024
Q2 		$12.9M Buy
149,407
+15,140
+11% +$1.22M 0.01% 1018
2024
Q1 		$11M Sell
134,267
-36,316
-21% -$2.84M 0.01% 1101
2023
Q4 		$11.3M Sell
170,583
-2,164
-1% -$150K 0.01% 1031
2023
Q3 		$12.6M Buy
172,747
+17,317
+11% +$1.17M 0.01% 902
2023
Q2 		$9.81M Sell
155,430
-15,834
-9% -$918K 0.01% 1066
2023
Q1 		$10.1M Buy
171,264
+42,510
+33% +$2.58M 0.01% 1023
2022
Q4 		$7.94M Buy
128,754
+18,127
+16% +$1.22M 0.01% 1131
2022
Q3 		$7.43M Sell
110,627
-43,868
-28% -$2.78M 0.01% 1125
2022
Q2 		$9.48M Sell
154,495
-5,615
-4% -$360K 0.01% 1009
2022
Q1 		$10.8M Buy
160,110
+58,263
+57% +$3.15M 0.01% 1024
2021
Q4 		$4.51M Sell
101,847
-8,575
-8% -$499K ﹤0.01% 1626
2021
Q3 		$7.15M Buy
110,422
+4,920
+5% +$342K 0.01% 1266
2021
Q2 		$8.49M Buy
105,502
+12,169
+13% +$927K 0.01% 1170
2021
Q1 		$6.35M Sell
93,333
-66,184
-41% -$5.2M 0.01% 1285
2020
Q4 		$11.1M Sell
159,517
-86,420
-35% -$5.38M 0.01% 892
2020
Q3 		$12.6M Sell
245,937
-37,809
-13% -$2.08M 0.02% 745
2020
Q2 		$16.6M Sell
283,746
-13,197
-4% -$730K 0.02% 598
2020
Q1 		$15M Buy
296,943
+2,573
+0.9% +$171K 0.02% 563
2019
Q4 		$21.8M Buy
294,370
+145,506
+98% +$9.08M 0.03% 542
2019
Q3 		$8.51M Buy
148,864
+80,713
+118% +$5.36M 0.01% 939
2019
Q2 		$4.46M Buy
68,151
+9,268
+16% +$645K 0.01% 1277
2019
Q1 		$4.36M Buy
58,883
+3,737
+7% +$263K 0.01% 1258
2018
Q4 		$3.29M Sell
55,146
-198
-0.4% -$16K 0.01% 1333
2018
Q3 		$5.22M Buy
55,344
+5,644
+11% +$486K 0.01% 1188
2018
Q2 		$3.73M Buy
49,700
+984
+2% +$70.7K 0.01% 1357
2018
Q1 		$2.95M Buy
48,716
+9,687
+25% +$524K 0.01% 1452
2017
Q4 		$1.82M Buy
39,029
+345
+0.9% +$17.1K ﹤0.01% 1750
2017
Q3 		$1.96M Sell
38,684
-18,782
-33% -$874K ﹤0.01% 1666
2017
Q2 		$2.86M Buy
57,466
+14,355
+33% +$671K 0.01% 1351
2017
Q1 		$1.83M Sell
43,111
-14,194
-25% -$628K ﹤0.01% 1582
2016
Q4 		$2.32M Buy
+57,305
New +$2.21M 0.01% 1391

Other funds holding HQY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Raymond James & Associates's HQY Position: Q3 2024 in Review

Raymond James & Associates increased its HealthEquity (HQY) stake by 1.3% in Q3 2024, buying an estimated $147K and bringing the position to 151,318 shares worth $12.4M. The position accounts for 0.01% of the portfolio, ranked #1096.

Raymond James & Associates first reported a position in HQY in Q4 2016 and has held it in 32 quarters since. The position peaked at $21.8M in Q4 2019. 403 funds tracked by Wall St. Rank hold HQY as of Q3 2024.

  • Raymond James & Associates held 151,318 shares of HealthEquity worth $12.4M as of Q3 2024.
  • Raymond James & Associates bought 1,911 HealthEquity shares in Q3 2024, an estimated $147K.
  • HealthEquity made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1096 holding.
  • Raymond James & Associates first reported a position in HealthEquity in Q4 2016 and has held it in 32 quarters since.
  • Raymond James & Associates's HealthEquity position peaked at $21.8M in Q4 2019.
  • 403 funds tracked by Wall St. Rank held HealthEquity as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.